NCT06660862 2026-01-08
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
University of Chicago
Phase 4 Not yet recruiting
Clinical Trials
5 trialsNCT06947577 2025-08-20
PEMFTEPCHIN
Cairo University
Phase 4 Completed
NCT04320316 2022-10-07
ENS
University of Alabama at Birmingham
Phase 4 Completed
NCT03610022 2022-08-18
OPTIVISMO-1
University Hospital, Bordeaux
Phase 4 Completed
NCT00378729 2011-10-04
PERCING
Assistance Publique - Hôpitaux de Paris
Phase 4 Unknown